Found 0 matching trials
To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea PHASE3 The objective of this study is to investigate the safety and efficacy of (0...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents PHASE3 To evaluate the safety, compliance, and pharmacokinetics profile of estetro...
Show More Location
KVL Medical Office/KVL Arstikabinet
Learn More & Join Trial
Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study NA The purpose of this study is to study the effect of Drospirenone on cervica...
Show More Location
Chulalongkorn University
Learn More & Join Trial
Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone PHASE3 The use of combined oral contraceptives has been associated with increased ...
Show More Location
Marcelo Gil Nisenbaum
Learn More & Join Trial
Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females PHASE3 This study will be in two parts, Part A and Part B. The primary objective o...
Show More Location
Alabama Clinical Therapeutics, LLC
Learn More & Join Trial
Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women PHASE3 The objective of the study is to evaluate the effects of Angeliq on BP over...
Show More Location
Multiple Locations
Learn More & Join Trial
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study PHASE3 The objectives of this study are to evaluate the contraceptive efficacy, va...
Show More Location
Hopital Saint-Pierre
Learn More & Join Trial
Comparative Trial in Hormone Withdrawal Associated Symptoms PHASE3 This clinical research study will examine whether an oral contraceptive pil...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles PHASE3 To demonstrate the contraceptive efficacy of LF111 . To demonstrate the saf...
Show More Location
Alabama Clinical Therapeutics
Learn More & Join Trial
Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function PHASE3 The objective of the study is to evaluate the effect of the dispenser's buz...
Show More Location
Multiple Locations
Learn More & Join Trial